SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
KALOBIOS PHARMACEUTICALS INC
(NQNM:KBIO Last Sale: 5.745 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (KBIO : $5.745)
$139 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 11/06/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Focus is Humaneered® antibody technology. Produced a portfolio of patient-targeted antibodies to treat serious medical conditions with a primary clinical focus on respiratory diseases and cancer. IPO at $8 January 30, 2013. Raised $70 million, selling 8.8 million shares, 36% of the outstanding. Lead Manager: Leerink Swann.
Historical Charts    Technical Analysis
No Historical Data available for KBIO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common KBIO $5.745 $ 0 $5.67 $5.8 53,619 $4.811 $8.25 24,128
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $138,615

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex